Search Results 401-410 of 2447 for 2024embarking
Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...
All study subjects will receive acalabrutinib, durvalumab, and venetoclax. Acalabrutinib is FDA approved for treatment of chronic lymphocytic leukemia and small ...
The purpose of this study is to study the handling of ovarian tissue, cryopreservation technology, and oocyte maturation for female pediatric cancer ...
Learn about this common cancer, including information on prevention, symptoms, diagnosis and treatment.
The purpose of this study is address one portion of the impending FAA critical manpower shortage and testing access concerns by developing telemedicine kiosks ...
The purpose of this study is to compare the effects of hormone therapy (androgen deprivation) and radiation therapy to the prostate gland and seminal vesicles ...
The purpose of this study is to compare, in a non-inferiority fashion, the progression-free survival (PFS) in patients with metastatic refractory gastric/ ...
About this study. This randomized trial will compare treatment strategies for proliferative diabetic retinopathy (PDR). Participants will receive either ...
ROCHESTER, Minn. — Researchers from the Mayo Clinic Comprehensive Cancer Center are set to present key research findings, including two late-breaking abstracts, ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your gift to celebrate this day advances our doctors’ lifesaving work.